Overview

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to see if receiving a transplant of blood stem cells (cells that can produce blood) or bone marrow from either a related donor (brother, sister or other relative) or an unrelated voluntary donor will help patients with advanced cutaneous T-cell lymphoma. The length of time that patients who receive the treatment remain free of disease will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Antilymphocyte Serum
Fludarabine
Fludarabine phosphate
Melphalan
Thymoglobulin
Vidarabine